M
Michael R. Shurin
Researcher at University of Pittsburgh
Publications - 203
Citations - 9478
Michael R. Shurin is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Dendritic cell & Immune system. The author has an hindex of 54, co-authored 203 publications receiving 8228 citations. Previous affiliations of Michael R. Shurin include Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis
TL;DR: It is confirmed by showing that rats exposed to electric footshock, physical restraint, or a conditioned aversive stimulus have increased levels of plasma IL-6, and the kinetics of the increase resembled that of increase in plasma corticosterone, which suggests that increased plasmaIL-6 may be part of the hormonal responses to stress.
Journal ArticleDOI
Dendritic cells in the cancer microenvironment.
TL;DR: Better understanding of DC immunobiology in cancer is pivotal for designing novel or improved therapeutic approaches that will allow proper functioning of DCs in patients with cancer.
Journal ArticleDOI
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation
Irena Kaplanov,Yaron Carmi,Rachel Kornetsky,Avishai Shemesh,Galina V. Shurin,Michael R. Shurin,Charles A. Dinarello,Elena Voronov,Ron N. Apte +8 more
TL;DR: Microenvironmental IL-1β is defined as a master cytokine in tumor progression using a model of orthotopically introduced 4T1 breast cancer cells and the combination of anti–IL-1 β plus anti–PD-1 abrogated the tumors completely.
Journal Article
Neuroblastoma-derived Gangliosides Inhibit Dendritic Cell Generation and Function
Galina V. Shurin,Michael R. Shurin,Svetlana N. Bykovskaia,Jeffrey Shogan,Michael T. Lotze,Edward M. Barksdale +5 more
TL;DR: It is demonstrated that NB-derived gangliosides inhibit the generation of functionally active DCs and may play a role in tumor-induced immunosuppression and subsequent tumor escape from immune recognition and elimination.
Journal ArticleDOI
Th1/Th2 balance in cancer, transplantation and pregnancy.
TL;DR: Successful interventions to regulate Thl/Th2 balance and modify the immune response may decrease the risk of development or relapse of malignancy, avoid impairment of donor cell engraftment, and allow successful fetal maturation.